Cargando…
Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
Gut microbiota refers to the diverse community of more than 100 trillion microorganisms residing in our intestines. It is now known that any shift in the composition of gut microbiota from that present during the healthy state in an individual is associated with predisposition to multiple pathologic...
Autores principales: | Shui, Lin, Yang, Xi, Li, Jian, Yi, Cheng, Sun, Qin, Zhu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978681/ https://www.ncbi.nlm.nih.gov/pubmed/32010123 http://dx.doi.org/10.3389/fimmu.2019.02989 |
Ejemplares similares
-
Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy
por: Singh, Ankita, et al.
Publicado: (2023) -
Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy
por: Wu, Jianmin, et al.
Publicado: (2021) -
Potential Role of the Gut Microbiome In Colorectal Cancer Progression
por: Kim, Jaeho, et al.
Publicado: (2022) -
Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy
por: Zhou, Pei, et al.
Publicado: (2022) -
Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
por: Wan, Xueting, et al.
Publicado: (2021)